New Management Strategy of Pregnancies at Risk of Congenital Adrenal Hyperplasia Using Fetal Sex Determination in Maternal Serum: French Cohort of 258 Cases (2002–2011)
The DOI matches its Crossref record; 40 of the 44 references it cites were found in a registry or an index.
Abstract
CONTEXT: Prenatal dexamethasone (DEX) treatment has been proposed since 1984 to prevent genital virilization in girls with congenital adrenal hyperplasia (CAH). DEX is effective in CAH females if initiated before the sixth week of gestation, but its safety in children treated in utero remains controversial regarding cognitive functions. OBJECTIVE: To avoid prenatal DEX in males and initiate DEX in due time in CAH females, we proposed in 2002 a protocol for fetal sex determination in the maternal serum (SRY test). DESIGN AND SETTING: We conducted a retrospective study of the management of 258 fetuses in the period 2002 through 2011 in pregnancies managed in referent medical centers with an institutional practice. PATIENTS: A total of 258 fetuses at risk of CAH (134 males and 124 females) were included. INTERVENTION: DEX was offered after informed consent to pregnant women. MAIN OUTCOME MEASURE: The sensitivity of an early SRY test was evaluated after data collection. RESULTS: The SRY test is sensitive from 4 weeks and 5 days of gestation. It avoided prenatal DEX in 68% of males, and this percentage increased over the years. DEX was maintained until prenatal diagnosis in non-CAH females. Virilization was prevented in 12 CAH girls treated at the latest at 6 weeks gestation and minimized in 3 girls treated between 6 and 7 weeks gestation. Maternal tolerance was correct. No fetal malformations were noted in the 154 children treated in utero. CONCLUSIONS: The SRY test is reliable to avoid prenatal DEX in males, but its application must be improved. Prenatal DEX should be maintained to prevent virilization and traumatic surgery in CAH girls after informed consent and information provided to families about the benefit to risk ratio in limiting hyperandrogenism during fetal life. Our large multicentric French cohort has helped to better assess the risks previously reported.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In a study of prenatal treatment in 258 fetuses at risk for CAH from 2002 to 2011, testing for Y-chromosome DNA prevented treatment with Dex in only 68% of male fetuses, although the percentage rose during the course of the study (97).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [97]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Unlike fetal cells, it disappears from the maternal circulation shortly after delivery (319,320) and therefore does not confound prenatal genetic investigations in subsequent pregnancies (321,322).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [322]
Experimental — accuracy not yet measuredIn the citing paper
“In a 10-year French study, among 112 treated female fetuses, 14 had 21-hydroxylase-deficient CAH and three had 11-hydroxylase-deficient CAH; of these 17 girls, 12 had normal female genitalia at birth and 3 had moderate virilization, whereas 2 who were treated late were severely virilized (97).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [97]
In the citing paper
“Aside from individual case reports, only two series of prenatal treatment of CAH have appeared since August 2009.”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Presence of fetal DNA in maternal plasma and serum
Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02174-0 · Cited by 3,129
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Developmental and Functional Biology of the Primate Fetal Adrenal Cortex*
Mesiano, S., & Jaffe, R. B. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0304 · Cited by 680
Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus
Uno, H., Lohmiller, L., Thieme, C., Kemnitz, J. W., Engle, M. J., Roecker, E. B., & Farrell, P. M. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90002-g · Cited by 502
(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Joint LWPES/ESPE CAH Working Group (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020611 · Cited by 332
In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development
Goto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25091 · Cited by 284
New, M. I., Carlson, A., Obeid, J., Marshall, I., Cabrera, M. S., Goseco, A., Lin-Su, K., Putnam, A. S., Wei, J. Q., & Wilson, R. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8072 · Cited by 263
Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency
David, M., & Forest, M. G. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80310-8 · Cited by 256
Self-citationCrouch, N. S., Liao, L. M., Woodhouse, C. R. J., Conway, G. S., & Creighton, S. M. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.079 · Cited by 249
Hirvikoski, T., Nordenström, A., Lindholm, T., Lindblad, F., Ritzén, E. M., Wedell, A., & Lajic, S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1340 · Cited by 228
Mercado, A. B. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.7.2014 · Cited by 203
Gastaud, F., Bouvattier, C., Duranteau, L., Brauner, R., Thibaud, E., Kutten, F., & Bougnères, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1757 · Cited by 192
First‐trimester fetal sex determination in maternal serum using real‐time PCR
Costa, J., Benachi, A., Gautier, E., Jouannic, J., Ernault, P., & Dumez, Y. (2001) · Prenatal Diagnosis · doi:10.1002/pd.219 · Cited by 177
Self-citationForest, M. G., Bétuel, H., & David, M. (1989) · Endocrine Research · doi:10.1080/07435808909039101 · Cited by 172
Self-citationPrenatal diagnosis and treatment of 21-hydroxylase deficiency
Forest, M. G., David, M., & Morel, Y. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90125-g · Cited by 171
Self-citationNon-invasive prenatal determination of fetal sex: translating research into clinical practice
Hill, M., Finning, K., Martin, P., Hogg, J., Meaney, C., Norbury, G., Daniels, G., & Chitty, L. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01533.x · Cited by 168
Long-Term Somatic Follow-Up of Prenatally Treated Children with Congenital Adrenal Hyperplasia1
Lajic, S., Wedell, A., Bui, T.-H., Ritzén, E. M., & Holst, M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5233 · Cited by 164
Nordenström, A., Frisén, L., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., & Nordenskjöld, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2639 · Cited by 161
Clinical and Molecular Genetics of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Morel, Y., & Miller, W. L. (1991) · Advances in Human Genetics · doi:10.1007/978-1-4684-5958-6_1 · Cited by 158
Self-citationSonographic Fetal Sex Determination
Odeh, M., Grinin, V., Kais, M., Ophir, E., & Bornstein, J. (2009) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318193299b · Cited by 137
Meyer-Bahlburg, H. F. L., Dolezal, C., Baker, S. W., Carlson, A. D., Obeid, J. S., & New, M. I. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021129 · Cited by 123
(1988) · PubMed · Cited by 110
Narasaka, T., Suzuki, T., Moriya, T., & Sasano, H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00445-7 · Cited by 109
Prenatal Treatment of Congenital Adrenal Hyperplasia
Forest, M. G., Morel, Y., & David, M. (1998) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(98)00067-8 · Cited by 107
Self-citationMercè Fernández‐Balsells, M., Muthusamy, K., Smushkin, G., Lampropulos, J. F., Elamin, M. B., Abu Elnour, N. O., Elamin, K. B., Agrwal, N., Gallegos‐Orozco, J. F., Lane, M. A., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03826.x · Cited by 101
Earliest gestational age for fetal sexing in cell‐free maternal plasma
Rijnders, R. J. P., van der Luijt, R. B., Peters, E. D. J., Goeree, J. K., van der Schoot, C. E., van Amstel, H. K. P., & Christiaens, G. C. M. L. (2003) · Prenatal Diagnosis · doi:10.1002/pd.750 · Cited by 96
Early detection of cell-free fetal DNA in maternal plasma
Illanes, S. E., Denbow, M. L., Kailasam, C., Finning, K. M., & SOOTHILL, P. W. (2007) · Early Human Development · doi:10.1016/j.earlhumdev.2006.11.001 · Cited by 94
Non-invasive prenatal diagnosis of single-gene disorders from maternal blood
Bustamante‐Aragonés, A., de Alba, M. R., Perlado, S., Trujillo-Tiebas, M. J., Arranz, J. P., Diaz-Recasens, J., Troyano-Luque, J. M., & Ramos, C. (2012) · Gene · doi:10.1016/j.gene.2012.04.045 · Cited by 85
Hirvikoski, T., Nordenström, A., Wedell, A., Ritzén, M., & Lajic, S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1222 · Cited by 80
Meyer-Bahlburg, H. F. L., Dolezal, C., Haggerty, R., Silverman, M., & New, M. I. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0789 · Cited by 76
Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Nimkarn, S., & New, M. I. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.027 · Cited by 69
Prenatal treatment of congenital adrenal hyperplasia
Lajic, S., Nordenstrom, A., Ritzen, E., & Wedell, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151u063 · Cited by 67
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Miller, W. L., & Witchel, S. F. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.885 · Cited by 62
Pang, S., & Clark, A. C. (1990) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(90)90068-e · Cited by 61
BARTHA, J. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00064-4 · Cited by 57
Forest, M. G., & Dörr, H. G. (2003) · The Endocrinologist · doi:10.1097/01.ten.0000081690.21823.af · Cited by 47
Dorr, H. G. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.1.117 · Cited by 42
p.H62L, a Rare Mutation of the CYP21 Gene Identified in Two Forms of 21-Hydroxylase Deficiency
Menassa, R., Tardy, V., Despert, F., Bouvattier-Morel, C., Brossier, J. P., Cartigny, M., & Morel, Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2701 · Cited by 38
Self-citationDesafíos quirúrgicos de las anomalías del desarrollo sexual
Gorduza, D. B., Vidal, I., Birraux, J., Gay, C.-L., Demede, D., Mure, P., & Mouriquand, P. D. E. (2010) · Archivos Españoles de Urología · doi:10.4321/s0004-06142010000700003 · Cited by 17
Research works printed but not linked: 2
- Gorduza D, Vidal I, Birraux J, et al. The surgical challenges of dis- orders of sex development (DSD). Arch Esp Urol. 2010;63:495- 504.
- Tardy V. Management of pregnancies at risk of 21-hydroxylase or 11-hydroxylase deficiency using fetal sex determination in maternal serum proposed in France since 2002: how to limit prenatal expo- sure to dexamethasone. Horm Res. 2009;70(Suppl 3):348.
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
New, M. I., Tong, Y. K., Yuen, T., Jiang, P., Pina, C., Chan, K. C. A., Khattab, A., Liao, G. J. W., Yau, M., Kim, S.-M., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1118 · Cited by 319
“A recent publication by Tardy-Guidollet et al (19) demonstrates their success in using the SRY probe for noninvasive prenatal sex determination.”
Surgery in disorders of sex development (DSD) with a gender issue: If (why), when, and how?
Mouriquand, P. D. E., Gorduza, D. B., Gay, C.-L., Meyer-Bahlburg, H. F. L., Baker, L., Baskin, L. S., Bouvattier, C., Braga, L. H., Caldamone, A. C., Duranteau, L., et al. (2016) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2016.04.001 · Cited by 250
Metadata
- Authors
- Tardy-Guidollet, V., Menassa, R., Costa, J.-M., David, M., Bouvattier-Morel, C., Baumann, C., Houang, M., Lorenzini, F., Philip, N., Odent, S., Guichet, A., & Morel, Y.
- Affiliations
- Hospices Civils de Lyon (FR)
- Département de Génétique (J.-M.C), Laboratoire Cerba, 95066 Cergy Pontoise, France;
- Hôpital Femme Mère Enfant (FR)
- Unité d'Endocrinologie pédiatrique (C.B.-M.), Centre Hospitalier de Bicêtre, 94275 Le Kremlin-Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France;
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Armand-Trousseau (FR)
- Hôpital Paule de Viguier (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Département de Génétique (S.O.), Hôpital Sud, 35203 Rennes, France;
- Centre Hospitalier Universitaire d'Angers (FR)
- Corresponding author
- Tardy-Guidollet, Véronique
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2014-04-01
- Volume
- 99
- Issue
- 4
- Pages
- 1180-1188
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2064123952
- Cited by
- 96
- References
- 44
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 8 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 13 · 2017: 7 · 2016: 11 · 2015: 14 · 2014: 4
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- congenital adrenal hyperplasia, prenatal dexamethasone, fetal sex determination, SRY gene, maternal serum, prenatal diagnosis, hyperandrogenism, pregnancy management
- MeSH terms
- Adrenal Hyperplasia, Congenital, Blood Chemical Analysis, Dexamethasone, Female, France, Humans, Male, Maternal-Fetal Exchange, Pregnancy, Prenatal Diagnosis, Risk Factors, Sex Determination Analysis, Virilism, Cohort Studies, Fetal Therapies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.